Related Experiment Video

Updated: Jan 12, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K

Clinical and echocardiographic outcomes of combined CABG and MV repair

Rajat Sindwani1, Gurmeet Singh1, Harneet Singh Khurana2

  • 1Department of Cardiothoracic and Vascular Surgery, Hero Heart DMC Institute, Ludhiana, Punjab, India.

Bioinformation
|October 31, 2025
PubMed

Insights

Coronary Artery Bypass Grafting with mitral valve repair effectively treats moderate to severe mitral regurgitation, improving patient outcomes and eliminating residual regurgitation in most cases.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Cardiac Valve Repair

Background:

  • Moderate to severe mitral regurgitation (MR) often coexists with coronary artery disease (CAD).
  • Surgical intervention for both conditions requires careful patient selection and procedural planning.

Purpose of the Study:

  • To evaluate the outcomes of patients undergoing Coronary Artery Bypass Grafting (CABG) with concomitant mitral valve (MV) repair for moderate to severe MR.
  • To assess the efficacy and safety of this combined surgical approach in a high-comorbidity patient population.

Main Methods:

  • A mixed-method observational study design was employed.
  • Patients undergoing CABG with MV repair for moderate to severe MR were evaluated.
  • Data collected included patient demographics, comorbidities, and clinical outcomes at discharge and 12 months.

Main Results:

  • The study population predominantly consisted of males aged 61-70 years with high rates of Type 2 diabetes and triple-vessel CAD.
  • At discharge, 94.7% of patients improved to NYHA class II.
  • Residual MR was eliminated in 97.1% of patients by discharge, with sustained improvement at 12 months.

Conclusions:

  • CABG with concomitant MV repair is a viable and effective treatment option for patients with moderate to severe MR and concomitant CAD.
  • This combined surgical approach demonstrates significant improvement in functional status and successful elimination of MR, even in patients with substantial comorbidities.

Keywords:
Effective regurgitant orifice areaNew York Heart Association (NYHA)coronary artery bypasses graftingischemic heart diseasesecondary mitral regurgitation

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
209
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
399
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
355
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
264